Intraocular lymphoma diagnosed by fine-needle aspiration biopsy. 2010

Shaden Sarafzadeh, and Zélia M Corrêa, and Ashima Dhamija, and James J Augsburger, and Nikolaos Trichopoulos
Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

OBJECTIVE To describe clinical experience in the diagnosis of intraocular lymphoma by fine-needle aspiration biopsy (FNAB) in patients with one or more discrete intraocular infiltrative lesions and limited or absent intravitreal tumour cells. METHODS Retrospective descriptive analysis of patients who underwent intraocular FNAB of a solid retinal, subretinal pigment epithelial or uveal tumour that proved to be a malignant lymphoma. RESULTS After exclusions, our study group consisted of seven patients, each of whom had one or more discrete intraocular infiltrative lesions and limited or absent intravitreal tumour cells and underwent a diagnostic intraocular FNAB that confirmed malignant intraocular lymphoma cytopathologically. These included three patients with one or more geographic yellow subretinal pigment epithelial infiltrates and one patient each with a prominent nodular white subretinal pigment epithelial tumour, a rapidly developing solid placoid choroidal mass, a haemorrhagic retinal infiltrative lesion and an infiltrative iris tumour, respectively. A prominent feature of virtually all aspirates was a large proportion of degenerated lymphoid cells in the background. Cytologically intact tumour cells ranged from relatively homogeneous small round cells with large nucleus to cytoplasm ratio to pleomorphic large cells with irregular knob-like nuclear protrusions. Immunocytochemical stains for lymphoid markers were helpful in confirming the pathological diagnosis of lymphoma in the five patients in whom this testing was performed. CONCLUSIONS FNAB was a useful diagnostic tool in the described subgroup of patients with suspected intraocular lymphoma. FNAB should be considered as a diagnostic option in selected patients with suspected intraocular lymphoma, especially if there are few or no vitreous cells.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D001918 Brachytherapy A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. Curietherapy,Implant Radiotherapy,Plaque Therapy, Radioisotope,Radioisotope Brachytherapy,Radiotherapy, Interstitial,Radiotherapy, Intracavity,Radiotherapy, Surface,Brachytherapy, Radioisotope,Interstitial Radiotherapy,Intracavity Radiotherapy,Radioisotope Plaque Therapy,Radiotherapy, Implant,Surface Radiotherapy,Therapy, Radioisotope Plaque
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D014604 Uveal Neoplasms Tumors or cancer of the UVEA. Neoplasm, Uveal,Neoplasms, Uveal,Uveal Neoplasm

Related Publications

Shaden Sarafzadeh, and Zélia M Corrêa, and Ashima Dhamija, and James J Augsburger, and Nikolaos Trichopoulos
January 2001, Retina (Philadelphia, Pa.),
Shaden Sarafzadeh, and Zélia M Corrêa, and Ashima Dhamija, and James J Augsburger, and Nikolaos Trichopoulos
August 2002, Retina (Philadelphia, Pa.),
Shaden Sarafzadeh, and Zélia M Corrêa, and Ashima Dhamija, and James J Augsburger, and Nikolaos Trichopoulos
July 2007, Cornea,
Shaden Sarafzadeh, and Zélia M Corrêa, and Ashima Dhamija, and James J Augsburger, and Nikolaos Trichopoulos
January 1985, Acta cytologica,
Shaden Sarafzadeh, and Zélia M Corrêa, and Ashima Dhamija, and James J Augsburger, and Nikolaos Trichopoulos
November 2010, Gastroenterologia y hepatologia,
Shaden Sarafzadeh, and Zélia M Corrêa, and Ashima Dhamija, and James J Augsburger, and Nikolaos Trichopoulos
August 2005, Diagnostic cytopathology,
Shaden Sarafzadeh, and Zélia M Corrêa, and Ashima Dhamija, and James J Augsburger, and Nikolaos Trichopoulos
February 2007, Diagnostic cytopathology,
Shaden Sarafzadeh, and Zélia M Corrêa, and Ashima Dhamija, and James J Augsburger, and Nikolaos Trichopoulos
June 2008, Journal of clinical microbiology,
Shaden Sarafzadeh, and Zélia M Corrêa, and Ashima Dhamija, and James J Augsburger, and Nikolaos Trichopoulos
December 1993, Diagnostic cytopathology,
Shaden Sarafzadeh, and Zélia M Corrêa, and Ashima Dhamija, and James J Augsburger, and Nikolaos Trichopoulos
January 2020, Journal of the American Society of Cytopathology,
Copied contents to your clipboard!